A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS)

Introduction: Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of androgen deprivation therapy (ADT) plus an additional systemic therapy, regardless of disease burden and risk, based on phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Karim, Safiya, Lowther, Jennifer, Gyulay, Gabriel, O’Sullivan, Dylan, Wallis, Christopher J. D., Yip, Steven M., Brenner, Darren R., Boyne, Devon J., Cheung, Winson Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528640/
https://www.ncbi.nlm.nih.gov/pubmed/37754506
http://dx.doi.org/10.3390/curroncol30090591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528640/
https://www.ncbi.nlm.nih.gov/pubmed/37754506
http://dx.doi.org/10.3390/curroncol30090591

Ejemplares similares